APA

Tirado-Gonzalez I., Czlonka E., Nevmerzhitskaya A., Soetopo D., Bergonzani E., Mahmoud A., Contreras A., Jeremias I., Platzbecker U., Bourquin J. P., Kloz U., Van der Hoeven F. & Medyouf H. (20190219). CRISPR/Cas9-edited NSG mice as PDX models of human leukemia to address the role of niche-derived SPARC. : Leukemia.

Chicago

Tirado-Gonzalez I, Czlonka E, Nevmerzhitskaya A, Soetopo D, Bergonzani E, Mahmoud A, Contreras A, Jeremias I, Platzbecker U, Bourquin J P, Kloz U, Van der Hoeven F and Medyouf H. 20190219. CRISPR/Cas9-edited NSG mice as PDX models of human leukemia to address the role of niche-derived SPARC. : Leukemia.

Harvard

Tirado-Gonzalez I., Czlonka E., Nevmerzhitskaya A., Soetopo D., Bergonzani E., Mahmoud A., Contreras A., Jeremias I., Platzbecker U., Bourquin J. P., Kloz U., Van der Hoeven F. and Medyouf H. (20190219). CRISPR/Cas9-edited NSG mice as PDX models of human leukemia to address the role of niche-derived SPARC. : Leukemia.

MLA

Tirado-Gonzalez I, Czlonka E, Nevmerzhitskaya A, Soetopo D, Bergonzani E, Mahmoud A, Contreras A, Jeremias I, Platzbecker U, Bourquin J P, Kloz U, Van der Hoeven F and Medyouf H. CRISPR/Cas9-edited NSG mice as PDX models of human leukemia to address the role of niche-derived SPARC. : Leukemia. 20190219.